Ceruloplasmin is a NO oxidase and nitrite synthase that determines endocrine NO homeostasis

Nature Chemical Biology

Volumn 2, Issue 9, 2006, Pages 486-493

  Shiva, Sruti ^a,b   Wang, Xunde ^a,b   Ringwood, Lorna A ^a,b   Xu, Xueying ^c   Yuditskaya, Susan ^a,b   Annavajjhala, Vidhya ^a   Miyajima, Hiroaki ^d   Hogg, Neil ^e   Harris, Zena Leah ^c   Gladwin, Mark T ^a,b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

^d HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e FREE RADICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUFFER; CERULOPLASMIN; HEMOGLOBIN; METAL; MULTICOPPER OXIDASE; NITRATE; NITRIC OXIDE; NITRIC OXIDE OXIDASE; NITRITE; NITRITE SYNTHASE; OXIDOREDUCTASE; OXYGEN; SYNTHETASE; UNCLASSIFIED DRUG;

ABNORMAL SUBSTRATE CONCENTRATION IN BLOOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CELL PROTECTION; CELL RESPIRATION; CHEMICAL REACTION KINETICS; CONGENITAL ACERULOPLASMINEMIA; CONTROLLED STUDY; ENDOCRINE FUNCTION; ENZYME ACTIVITY; ENZYME MECHANISM; FEMALE; HOMEOSTASIS; HUMAN; HUMAN CELL; HYDRATION; HYPOXIA; INFARCTION; ISCHEMIA; KNOCKOUT MOUSE; LIVER INFARCTION; LIVER ISCHEMIA; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; REPERFUSION INJURY; SIGNAL TRANSDUCTION; VASODILATATION;

EID: 33747602092     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio813     Document Type: Article

References (52)

1. Bryan, N.S. et al. Nitrite is a signaling molecule and regulator of gene expression in mammalian tissues. Nat. Chem. Biol. 1, 290-297 (2005).
2. Cosby, K. et al. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat. Med. 9, 1498-1505 (2003).
3. Crawford, J.H. et al. Hypoxia, red blood cells, and nitrite regulate NO-dependent hypoxic vasodilation. Blood 107, 566-574 (2006).
4. Gladwin, M.T. et al. The emerging biology of the nitrite anion. Nat. Chem. Biol. 1, 308-314 (2005).
5. Lundberg, J.O. & Weitzberg, E. NO generation from nitrite and its role in vascular control. Arterioscler. Thromb. Vasc. Biol. 25, 915-922 (2005).
6. Li, H., Samouilov, A., Liu, X. & Zweier, J.L. Characterization of the magnitude and kinetics of xanthine oxidase-catalyzed nitrite reduction. Evaluation of its role in nitric oxide generation in anoxic tissues. J. Biol. Chem. 276, 24482-24489 (2001).
7. Modin, A. et al. Nitrite-derived nitric oxide: a possible mediator of 'acidic-metabolic' vasodilation. Acta Physiol. Scand. 171, 9-16 (2001).
8. Zweier, J.L., Wang, P., Samouilov, A. & Kuppusamy, P. Enzyme-independent formation of nitric oxide in biological tissues. Nat. Med. 1, 804-809 (1995).
9. Nagababu, E., Ramasamy, S., Abernethy, D.R. & Rifkind, J.M. Active nitric oxide produced in the red cell under hypoxic conditions by deoxyhemoglobin-mediated nitrite reduction. J. Biol. Chem. 278, 46349-46356 (2003).
10. Duranski, M.R. et al. Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J. Clin. Invest. 115, 1232-1240 (2005).
11. Webb, A. et al. Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage. Proc. Natl. Acad. Sci. USA 101, 13683-13688 (2004).
12. O'Donnell, V.B. et al. Nitration of unsaturated fatty acids by nitric oxide-derived reactive nitrogen species peroxynitrite, nitrous acid, nitrogen dioxide, and nitronium ion. Chem. Res. Toxicol. 12, 83-92 (1999).
13. Hazen, S.L. et al. Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: pathways for monocyte-mediated protein nitration and lipid peroxidation in vivo. Circ. Res. 85, 950-958 (1999).
14. Bryan, N.S. et al. Cellular targets and mechanisms of nitros(yl)ation: an insight into their nature and kinetics in vivo. Proc. Natl. Acad. Sci. USA 101, 4308-4313 (2004).
15. Huang, K.T. et al. The reaction between nitrite and deoxyhemoglobin. Reassessment of reaction kinetics and stoichiometry. J. Biol. Chem. 280, 31126-31131 (2005).
16. Huang, Z. et al. Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control. J. Clin. Invest. 115, 2099-2107 (2005).
17. Dejam, A. et al. Erythrocytes are the major intravascular storage sites of nitrite in human blood. Blood 106, 734-739 (2005).
18. Kleinbongard, P. et al. Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radic. Biol. Med. 35, 790-796 (2003).
19. Kim-Shapiro, D.B., Schechter, A.N. & Gladwin, M.T. Unraveling the reactions of nitric oxide, nitrite, and hemoglobin in physiology and therapeutics. Arterioscler. Thromb. Vasc. Biol. 26, 697-705 (2006).
20. Ford, P.C., Wink, D.A. & Stanbury, D.M. Autoxidation kinetics of aqueous nitric oxide. FEBS Lett. 326, 1-3 (1993).
21. Wang, X. et al. Biological activity of nitric oxide in the plasmatic compartment. Proc. Natl. Acad. Sci. USA 101, 11477-11482 (2004).
22. Lauer, T. et al. Direct biochemical evidence for eNOS stimulation by bradykinin in the human forearm vasculature. Basic Res. Cardiol. 98, 84-89 (2003).
23. Zhang, Y. & Hogg, N. Mixing artifacts from the bolus addition of nitric oxide to oxymyoglobin: implications for S-nitrosothiol formation. Free Radic. Biol. Med. 32, 1212-1219 (2002).
24. Rafikova, O., Rafikov, R. & Nudler, E. Catalysis of S-nitrosothiols formation by serum albumin: the mechanism and implication in vascular control. Proc. Natl. Acad. Sci. USA 99, 5913-5918 (2002).
25. Hellman, N.E. & Gitlin, J.D. Ceruloplasmin metabolism and function. Annu. Rev. Nutr. 22, 439-458 (2002).
26. Musci, G., Polticelli, F. & Calabrese, L. Structure/function relationships in ceruloplasmin. Adv. Exp. Med. Biol. 448, 175-182 (1999).
27. Harris, Z.L. et al. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc. Natl. Acad. Sci. USA 92, 2539-2543 (1995).
28. Sarkar, J., Seshadri, V., Tripoulas, N.A., Ketterer, M.E. & Fox, P.L. Role of ceruloplasmin in macrophage iron efflux during hypoxia. J. Biol. Chem. 278, 44018-44024 (2003).
29. Osaki, S., Johnson, D.A. & Frieden, E. The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J. Biol. Chem. 241, 2746-2751 (1966).
30. Torres, J. & Wilson, M.T. The reactions of copper proteins with nitric oxide. Biochim. Biophys. Acta 1411, 310-322 (1999).
31. Inoue, K. et al. Nitrosothiol formation catalyzed by ceruloplasmin. Implication for cytoprotective mechanism in vivo. J. Biol. Chem. 274, 27069-27075 (1999).
32. Hughes, M.N. Relationships between nitric oxide, nitroxyl ion, nitrosonium cation and peroxynitrite. Biochim. Biophys. Acta 1411, 263-272 (1999).
33. Meyer, L.A., Durley, A.P., Prohaska, J.R. & Harris, Z.L. Copper transport and metabolism are normal in aceruloplasminemic mice. J. Biol. Chem. 276, 36857-36861 (2001).
34. Miyajima, H. Aceruloplasminemia, an iron metabolic disorder. Neuropathology 23, 345-350 (2003).
35. Harris, Z.L. Aceruloplasminemia. J. Neurol. Sci. 207, 108-109 (2003).
36. Xu, X., Pin, S., Gathinji, M., Fuchs, R. & Harris, Z.L. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Ann. NY Acad. Sci. 1012, 299-305 (2004).
37. Yoshida, K. et al. Increased lipid peroxidation in the brains of aceruloplasminemia patients. J. Neurol. Sci. 175, 91-95 (2000).
38. Harada, H. et al. Selected contribution: effects of gender on reduced-size liver ischemia and reperfusion injury. J. Appl. Physiol. 91, 2816-2822 (2001).
39. Fox, P.L., Mukhopadhyay, C. & Ehrenwald, E. Structure, oxidant activity, and cardiovascular mechanisms of human ceruloplasmin. Life Sci. 56, 1749-1758 (1995).
40. Gitlin, J.D. Transcriptional regulation of ceruloplasmin gene expression during inflammation. J. Biol. Chem. 263, 6281-6287 (1988).
41. Torres, J., Sharpe, M.A., Rosquist, A., Cooper, C.E. & Wilson, M.T. Cytochrome c oxidase rapidly metabolises nitric oxide to nitrite. FEBS Lett. 475, 263-266 (2000).
42. Martin, F. et al. Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation. Blood 105, 4613-4619 (2005).
43. Mukhopadhyay, C.K., Mazumder, B. & Fox, P.L. Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency. J. Biol. Chem. 275, 21048-21054 (2000).
44. Singh, T.K. Serum ceruloplasmin in acute myocardial infarction. Acta Cardiol. 47, 321-329 (1992).
45. Ehrenwald, E., Chisolm, G.M. & Fox, P.L. Intact human ceruloplasmin oxidatively modifies low density lipoprotein. J. Clin. Invest. 93, 1493-1501 (1994).
46. Fox, P.L., Mazumder, B., Ehrenwald, E. & Mukhopadhyay, C.K. Ceruloplasmin and cardiovascular disease. Free Radic. Biol. Med. 28, 1735-1744 (2000).
47. Miyajima, H., Takahashi, Y., Serizawa, M., Kaneko, E. & Gitlin, J.D. Increased plasma lipid peroxidation in patients with aceruloplasminemia. Free Radic. Biol. Med. 20, 757-760 (1996).
48. Miyajima, H. et al. Increased very long-chain fatty acids in erythrocyte membranes of patients with aceruloplasminemia. Neurology 50, 130-136 (1998).
49. Miyajima, H. et al. Increased oxysterols associated with iron accumulation in the brains and visceral organs of acaeruloplasminaemia patients. QJM 94, 417-422 (2001).
50. Yang, B.K., Vivas, E.X., Reiter, C.D. & Gladwin, M.T. Methodologies for the sensitive and specific measurement of S-nitrosothiols, iron-nitrosyls, and nitrite in biological samples. Free Radic. Res. 37, 1-10 (2003).
51. Lim, M.D., Lorkovic, I.M. & Ford, P.C. The preparation of anaerobic nitric oxide solutions for the study of heme model systems in aqueous and nonaqueous media: some consequences of NO x impurities. Methods Enzymol. 396, 3-17 (2005).
52. Sunderman, F.W., Jr & Nomoto, S. Measurement of human serum ceruloplasmin by its p-phenylenediamine oxidase activity. Clin. Chem. 16, 903-910 (1970).